MCK
Stock Details
MCK is McKesson Corporation's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 320.28$. Average daily volumn in 3 months 1.2M. Market cap 46.17B
Stock symbol : MCK. Exchange : NYSE. Currency : USD Lastest price : 321.55$. Total volume : 2.90M. Market state CLOSED Click reload if you want to check the lastest price on market!!!
McKesson Corporation (MCK)
Last Price
321.55$Change
6.89Volume
2.90M
| Previous Close | 314.66 |
| Open | 317.06 |
| Day Range | 310.37-322.11 |
| Bid | 308.94 x 1k |
| Ask | 321.54 x 1.2k |
| Volume | 2.9M |
| Average Volume | 1.2M |
| Market Cap | 46.17B |
| Beta | 0.66 |
| 52 Week Range | 186.61-339.94 |
| Trailing P/E | 44.29 |
| Foward P/E | 12.61 |
| Dividend (Yield %) | 0.58% |
| Ex-Dividend Date | 2022-05-31 |
Financial Details
Organization
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business soluti... ons to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Market Cap:
46.17BRevenue:
263.97BTotal Assets:
63.3BTotal Cash:
3.53B
News about "McKesson Corporation"
McKesson's (MCK) Latest JV to Boost Cancer Treatment Options
Source from : Nasdaq - 1 days ago
The JV will combine McKesson’s US Oncology Research (“USOR”) and HCA Healthcare’s Sarah Cannon Research Institute (“SCRI”). Following the completion of the deal, which is expected to close in 2022, ...See details»
McKesson, HCA Healthcare To Form JV For Cancer Research
Source from : Nasdaq - 2 days ago
McKesson Corporation (MCK) and HCA Healthcare, Inc. (HCA), said on Thursday that they have inked a deal to form a joint venture by combining McKesson's US Oncology Research or USOR and HCA ...See details»
Brookstone Capital Management Cuts Position in McKesson Co. (NYSE:MCK)
Source from : Defense World - 2 days ago
Brookstone Capital Management lessened its stake in McKesson Co. (NYSE:MCK – Get Rating) by 1.9% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission ...See details»
McKesson: Best Of Breed In Drug Distributor Oligopoly
Source from : Seeking Alpha - 5 days ago
McKesson's value proposition is best of breed in the healthcare distributor oligopoly. Read why investors should take a deeper look at this stock.See details»
It's official: HCA announces Sarah Cannon joint venture with McKesson
Source from : The Business Journals - 2 days ago
HCA Healthcare Inc. and McKesson Corporation are joining their oncology research forces to form a new joint venture ...See details»
Moody National Bank Trust Division Lowers Stock Position in McKesson Co. (NYSE:MCK)
Source from : Defense World - 2 days ago
Moody National Bank Trust Division decreased its holdings in McKesson Co. (NYSE:MCK – Get Rating) by 12.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC.See details»
Moody National Bank Trust Division Has $1.07 Million Holdings in McKesson Co. (NYSE:MCK)
Source from : ETF Daily News - 2 days ago
0.21% of the stock is owned by insiders. About McKesson (Get Rating) McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and ...See details»
Health care giants McKesson and HCA partner up in cancer research joint venture
Source from : Dallas Morning News - 2 days ago
Two big names in health care are joining forces to expand clinical cancer research. Irving-based McKesson Corp. and HCA Healthcare, parent company of the Medical City hospitals in Dallas-Fort Worth, ...See details»
HCA and McKesson combine research subsidiaries
Source from : Nashville Post - 2 days ago
HCA Healthcare and the McKesson Corporation are forming a joint venture between their respective oncology research arms Sarah Cannon Research Institute and US Oncology Research. The subsidiaries of ...See details»
McKesson Corporation: McKesson's Position in the Drug Distribution Oligopoly Warrants a Narrow Moat
Source from : YAHOO!Finance - 12 days ago
Find the latest McKesson Corporation (MCK) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance ...See details»
Wedge Capital Management L L P NC Reduces Holdings in McKesson Co. (NYSE:MCK)
Source from : ETF Daily News - 3 days ago
McKesson Profile (Get Rating) McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the ...See details»
DI People: McKesson, CBRE, Axxess, RumbleOn, and More Make Leadership Moves
Source from : Dallas Innovates - 1 days ago
In this week’s roundup of hires, promotions, and accolades in North Texas, you’ll also find news from Gaedeke Group, Simpli.fi, Signify Health, Dallas Market Center, DartPoints, Mass Luminosity, and ...See details»
McKesson Forms Joint Venture with HCA Healthcare to Fight Cancer
Source from : Dallas Innovates - 2 days ago
Two giants in their industry are teaming up to accelerate cancer research. A research arm of Irving-based pharmaceutical distributor and health care services firm McKesson is forming a joint venture ...See details»
Another opioid trial looms for West Virginia, opioid distributors
Source from : Charleston Gazette-Mail - 6 days ago
Governments in West Virginia are gearing up for another civil trial in which three opioid distribution companies are accused of helping to create the opioid crisis.See details»